H.R. 1509

119th CongressIn committee

Accelerating Kids’ Access to Care Act of 2025

Sponsored by Lori Trahan (Democrat-MA-3)

Healthcare Costs & Access Healthcare & Public Health

Cosponsors

104

Actions

Roll calls

Amendments

Related bills

Actions

Feb 21, 2025 · Library of Congress

Introduced in House

Feb 21, 2025 · Library of Congress

Introduced in House

Feb 21, 2025 · House floor actions

Referred to the House Committee on Energy and Commerce.

Latest activity

Activity

July 2026

Lobbying reported · American Heart Association · Jul 21

American Heart Association reported 2nd Quarter (Apr 1 - June 30) lobbying for American Heart Association — $400,000

Lobbying reported · National Association Of Childrens Hospitals And Affiliates · Jul 20

National Association Of Childrens Hospitals And Affiliates reported 2nd Quarter (Apr 1 - June 30) lobbying for National Association Of Children's Hospitals — $1,370,000

BillsH.R. 169 H.R. 1262 H.R. 1509 H.R. 1735 H.R. 2483 H.R. 2587 H.R. 3505 H.R. 3890 H.R. 4768 H.R. 4798 H.R. 5582 H.R. 6396 S. 357 S. 752 S. 932 S. 2355 S. 2448

Lobbying reported · Blood Cancer United · Jul 20

Blood Cancer United reported 2nd Quarter (Apr 1 - June 30) lobbying for Blood Cancer United — $590,000

Lobbying reported · Dana-Farber Cancer Institute · Jul 20

Dana-Farber Cancer Institute reported 2nd Quarter (Apr 1 - June 30) lobbying for Dana-Farber Cancer Institute — $36,000

BillsH.R. 1262 H.R. 1300 H.R. 1509 S. 752

Lobbying reported · National Multiple Sclerosis Society · Jul 20

National Multiple Sclerosis Society reported 2nd Quarter (Apr 1 - June 30) lobbying for National Multiple Sclerosis Society — $66,189

Lobbying reported · National Alliance on Mental Illness (NAMI) · Jul 20

National Alliance on Mental Illness (NAMI) reported 2nd Quarter (Apr 1 - June 30) lobbying for National Alliance on Mental Illness (NAMI) — $20,000

BillsH.R. 1 H.R. 169 H.R. 247 H.R. 438 H.R. 553 H.R. 577 H.R. 608 H.R. 912 H.R. 929 H.R. 957 H.R. 1096 H.R. 1305 H.R. 1492 H.R. 1509 H.R. 1510 H.R. 1582 H.R. 1735 H.R. 1867 H.R. 1902 H.R. 1987 H.R. 2028 H.R. 2036 H.R. 2082 H.R. 2085 H.R. 2102 H.R. 2305 H.R. 2426 H.R. 2483 H.R. 2495 H.R. 2509 H.R. 2540 H.R. 2586 H.R. 2587 H.R. 2668 H.R. 2711 H.R. 2741 H.R. 2879 H.R. 2904 H.R. 2936 H.R. 2945 H.R. 3130 H.R. 3243 H.R. 3260 H.R. 3305 H.R. 3384 H.R. 3419 H.R. 3420 H.R. 3505 H.R. 3514 H.R. 3534 H.R. 3601 H.R. 3624 H.R. 3627 H.R. 3658 H.R. 3689 H.R. 3757 H.R. 3884 H.R. 4022 H.R. 4024 H.R. 4120 H.R. 4186 H.R. 4313 H.R. 4400 H.R. 4619 H.R. 4723 H.R. 4745 H.R. 4805 H.R. 5081 H.R. 5145 H.R. 5306 H.R. 5357 H.R. 5420 H.R. 5434 H.R. 5509 H.R. 5557 H.R. 5662 H.R. 5733 H.R. 5828 H.R. 6000 H.R. 6002 H.R. 6024 H.R. 6096 H.R. 6226 H.R. 6249 H.R. 6283 H.R. 6383 H.R. 6396 H.R. 6403 H.R. 6408 H.R. 6454 H.R. 6548 H.R. 6617 H.R. 6630 H.R. 6672 H.R. 6679 H.R. 6680 H.R. 6727 H.R. 6760 H.R. 6817 H.R. 6841 H.R. 6858 H.R. 6940 H.R. 7019 H.R. 7030 H.R. 7049 H.R. 7092 H.R. 7227 H.R. 7309 H.R. 7324 H.R. 7394 H.R. 7447 H.R. 7496 H.R. 7497 H.R. 7535 H.R. 7602 H.R. 7735 H.R. 7787 H.R. 7798 H.R. 7828 H.R. 7875 H.R. 7911 H.R. 7994 H.R. 8070 H.R. 8081 H.R. 8115 H.R. 8122 H.R. 8124 H.R. 8149 H.R. 8160 H.R. 8201 H.R. 8209 H.R. 8261 H.R. 8486 H.R. 8487 H.R. 8493 H.R. 8499 H.R. 8504 H.R. 8676 H.R. 8690 H.R. 8743 H.R. 8776 H.R. 8916 H.R. 8961 H.R. 8976 H.R. 9396 H.Res. 441 H.Res. 542 H.Res. 1256 H.Res. 1290 H.Res. 1327 H.Res. 1329 S. 190 S. 219 S. 266 S. 332 S. 414 S. 473 S. 585 S. 600 S. 607 S. 609 S. 665 S. 683 S. 702 S. 752 S. 768 S. 825 S. 906 S. 921 S. 925 S. 926 S. 931 S. 942 S. 1007 S. 1056 S. 1261 S. 1477 S. 1611 S. 1655 S. 1720 S. 1748 S. 1797 S. 1816 S. 1843 S. 1878 S. 1897 S. 1912 S. 1924 S. 2131 S. 2248 S. 2282 S. 2336 S. 2446 S. 2532 S. 2556 S. 2709 S. 2825 S. 2826 S. 2847 S. 2853 S. 2903 S. 3042 S. 3139 S. 3199 S. 3271 S. 3300 S. 3431 S. 3448 S. 3461 S. 3486 S. 3521 S. 3522 S. 3690 S. 3698 S. 3714 S. 3750 S. 3783 S. 3840 S. 4001 S. 4076 S. 4149 S. 4202 S. 4210 S. 4261 S. 4288 S. 4468 S. 4481 S. 4514 S. 4552 S. 4640 S. 4754 S. 4819 S.Res. 208 S.Res. 710 S.Res. 714 S.Res. 727

Lobbying reported · Sarepta Therapeutics · Jul 20

Sarepta Therapeutics reported 2nd Quarter (Apr 1 - June 30) lobbying for Sarepta Therapeutics — $220,000

BillsH.R. 1509 H.R. 9260

Lobbying reported · Acadia Pharmaceuticals · Jul 20

Acadia Pharmaceuticals reported 2nd Quarter (Apr 1 - June 30) lobbying for Acadia Pharmaceuticals — $700,000

BillsH.R. 1 H.R. 1262 H.R. 1414 H.R. 1492 H.R. 1509 H.R. 3731 H.R. 6130 H.R. 9102 S. 752 S. 832 S. 932 S. 3267

Lobbying reported · The Children's Hospital Of Philadelphia · Jul 20

The Children's Hospital Of Philadelphia reported 2nd Quarter (Apr 1 - June 30) lobbying for The Children's Hospital Of Philadelphia — $230,000

BillsH.R. 1 H.R. 1509 S. 752

Lobbying reported · Faegre Drinker Biddle & Reath · Jul 20

Faegre Drinker Biddle & Reath reported 2nd Quarter (Apr 1 - June 30) lobbying for Boston Children's Hospital — $30,000

BillsH.R. 1509 S. 752

Lobbying reported · American Lung Association · Jul 20

American Lung Association reported 2nd Quarter (Apr 1 - June 30) lobbying for American Lung Association — $120,000

Lobbying reported · The Kpm Group DC · Jul 19

The Kpm Group DC reported 2nd Quarter (Apr 1 - June 30) lobbying for Praxis Precision Medicines — $40,000

BillsH.R. 1262 H.R. 1509 S. 752 S. 932

Lobbying reported · Leavitt Partners · Jul 15

Leavitt Partners reported 2nd Quarter (Apr 1 - June 30) lobbying for Orchard Therapeutics North America — $20,000

BillsH.R. 1509 S. 752

You’re all caught up.